This non-randomized, open label, active control, single group assignment, safety/efficacy study is ongoing, but not recruiting participants. The study has estimated enrollment of 20 participants.
RESTORe Suturing System (RS2) is a next-generation endoscopic suturing device designed for primary weight loss. It is used for Transoral Gastric Volume Reduction (TGVR) for weight management for Class II or low grade class III Obesity.
The official title of the trial is “Transoral Gastric Volume Reduction as an Intervention for Weight Management (TRIM): A Non-Randomized Multicenter Feasibility Study of Subjects With Class II or Low Grade Class III Obesity.”
